期刊文献+

利福霉素耐药结核分枝杆菌rpoB突变与利福布丁耐药水平的关系 被引量:3

Relationship between the mutations in rpoB gene and the level of rifabutin resistance of rifamycin-resistant Mycobacterium tuberculosis
下载PDF
导出
摘要 目的研究利福霉素耐药结核分枝杆菌rpoB基因突变与利福布丁耐药水平的相关性。方法倍比稀释法测定64株利福霉素耐药及6株敏感菌株对利福布丁的最低抑菌浓度(MIC),并分析其对异烟肼的耐药情况。同时对rpoB全基因扩增后测序,分析rpoB突变位点和突变性质与利福布丁MICs高低及多重耐药的关系。结果 6株敏感株rpoB未突变,MICs为0.25~0.50 mg/L。64株耐药株rpoB突变率为100%。37株利福布丁高度耐药(MICs≥4 mg/L)株中,S531L突变27株,H526R突变和Y389C突变各2株,S531W、H526Y、Q513K、V176F、D516Y联合Q253R突变与D516G联合L511P突变各1株。17株中度耐药(MICs 2~4 mg/L)株中,S531L突变16株,D516G联合L511P和S509R突变1株。10株低度耐药(MICs 0.25~1 ng/L)株中,L533P、H526L、H526S、D516V、D516Y单点突变各2株。93.75%(60/64)的利福霉素耐药株对异烟肼耐药。结论检测rpoB突变即可初步筛选多重耐药结核分枝杆菌;中、高水平利福布丁耐药株以S531L突变占绝对优势,rpoB突变位点及突变类型与利福布丁耐药水平有一定相关性。 Objective To study the relationship between the mutations in rpoB gene of rifamycin-resistant Mycobacterium tuberculosis (M. tuberculosis) and the level of rifabutin resistance. Methods The minimal inhibition concentrations(MICs) of 64 rifamycin-resistant isolates and 6 sensitive isolates of M. tuberculosis to rifabutin were determined by the dilution method, their isonicotinyl hydrazide (INH) resistance were analyzed. The whole rpoB gene were amplified and sequenced, then the relationship between the mutations in rpoB gene and the level of rifabutin resistance and multidrug resistance were analyzed. Results The sensitive isolates had no mutations in rpoB gene and their MICs were 0. 25 mg/L - 0. 50 mg/L. All rifamycin-resistant isolates had mutations in rpoB gene. Among 37 high-level rifabutin-resistant strains (MICs≥4 rag/L), mutations of S531L, H526R, and Y389C were found in 27, 2 and 2 isolates respectively, co-mutation of S531W, H526Y, QS13K, V176F, DS16Y and Q253R was in 1 strain, co-mutation of D516G and L511P was in 1 strain. Of 17 intermediated-level rifabutin-resistant strains (MICs 2 - 4 mg/L), 16 isolates were with S531L mutation and 1 with D516G combined with L511P and S509R mutation, respec- tively. Of 10 low-level rifabutin-resistant strains (MICs 0. 25 - 1 mg/L), single mutation of L533P, H526L, H526S, D516V, and D516Y were found in 2 isolates respectively. 93. 75% (60/64) of rifamycin-resistant isolates were also resistant to INH. Conclusion Detection of rpoB mutation can preliminarily screen multidrug-resistant M. tuberculosis; The predominant mutations of rpoB gene in high-and middle-level rifabutin-resistant isolates are S531L, the mutation positions and types of rpoB gene in M. tuberculosis correlates with the level of rifabutin resistance.
机构地区 广州市胸科医院
出处 《中国感染控制杂志》 CAS 2011年第6期401-404,共4页 Chinese Journal of Infection Control
基金 国家"十一五"重大专项(2008Z×10003-009)
关键词 结核分枝杆菌 抗药性 微生物 利福布丁 利福霉素 RPOB基因 突变 序列分析 Mycobacterium tuberculosis drug resistance, microbial rifabutin rifamycin rpoB gene mutation sequence analysis
  • 相关文献

参考文献7

  • 1World Health Organization. Muhidrug and extensively drug- resistant TB (M/XDR-TB), 2010 global report on surveil- lance and response[EB/OL]. (2010 - 03) [2011 - 07]. http:// whqlibdoc, who. int/publications/2010/9789241599191 _ eng. pdf.
  • 2World Health Organization. Guidelines for the programmatic management of drug-resistant tuberculosis. Emergency update 2008FEB/OLd. (2008 - 04) [2011 - 07]. http=//whqlibdoc. who. int/publications/2008/9789241547581_eng, pdf.
  • 3崔振玲,王洁,陆俊梅,黄晓辰,丁元生,胡忠义.结核分枝杆菌临床分离株药敏结果与耐药程度的关联分析[J].中华检验医学杂志,2010,33(12):1145-1149. 被引量:3
  • 4Cavusoglu C, Karaca-Derici Y, Bilgic A. In vitro activity of ri fabutin against rifarnpicin-resistant Mycol~cterium tuberculosis iso- lates with known rpoB mutations [J]. Clin Microbiol Infect,2004, 10(7) :662 - 665.
  • 5Williams D L, Spring L, Collins L, et al. Contribution of rpoB mutations to development of rifamycin cross-resistance in Mycobacterium tuberculosis [J]. Antimierob Agents Chemoth- er, 1998, 42(7) ~1853 - 1857.
  • 6庞茂银,张文宏,陈澍,胡忠义,翁心华.结核分枝杆菌rpoB基因突变与多重耐药及利福平耐药程度的相关性[J].复旦学报(医学版),2004,31(3):228-230. 被引量:9
  • 7Siu G K H, Zhang Y, Lau T C K, et al. Mutations outside the rifampicin resistance-determining region associated with rifampicin resistance in Mycobacterium tuberculosis [J]. J Antimicrob Che- mother, 2011, 66(9) : 730 - 733.

二级参考文献21

  • 1王生伟,张侠.1996—2006年南京地区结核病耐药状况分析[J].中国防痨杂志,2008,30(5):406-408. 被引量:13
  • 2姜君,杜德兵,向启云.宜昌市2002—2006年间住院肺结核患者耐药状况及趋势分析[J].中国防痨杂志,2008,30(4):369-370. 被引量:3
  • 3沈鑫,沈梅,桂晓虹,高谦,梅建.上海市流动人口的结核病耐药状况及相关因素分析[J].中华结核和呼吸杂志,2007,30(6):407-410. 被引量:30
  • 4Martin A,Morcillo N,Lemus D,et al.Multicenter study of MTT and resazurin assays for testing susceptibility to first-line antituberculosis drugs.Int J Tuberc Lung Dis,2005,9:901-906.
  • 5Raut U,Narang P,Mendiratta DK,et al.Evaluation of rapid MTT tube method for detection of drug susceptibility of Mycobacterium tuberculosis to rifampicin and isoniazid.Indian J Med Microbiol,2008,26:222-227.
  • 6World Health Organization.Guideline for surveillance of drug resistance in tuberculosis.Geneva:World Health Organization,2009.
  • 7World Health Organization.WHO/CDS/TB/2001.288 Guideline for drug susceptibility testing for second-line anti-tuberculosis drugs for DOT-plus.Geneva:World Health Organization,2009.
  • 8Clinical and Laboratory Standards Insititute.M24-A.Susceptibility testing of mycobacteria,nocardiae,and other aerobic actinomycetes; Approved standard.Wayne,PA:CLSI,2003.
  • 9Martin A,Morcillo N,Lemus D,et al.Multicenter study of MTT and resazurin assays for testing susceptibility to first-line antituberculosis drugs.Int J Tuberc Lung Dis,2005.9:901-906.
  • 10Foongladda S,Roengsanthia D,Arjrattanakool W,et al.Rapid and simple MTT method for rifampicin and isoniazid susceptibility testing of Mycobacterium tuberculosis.Int J Tuberc Lung Dis,2002,6:1118-1122.

共引文献10

同被引文献40

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部